Creso Pharma (ASX:CPH) announces merger with Red Light Holland

• Creso Pharma (CPH) announces plans to merge with Canadian magic truffle business Red Light Holland and form a new company
• The new business will be called The HighBrid Lab and will focus on the research, development and sales of cannabis and psychedelic products
• HighBrid will list on the Canadian Securities Exchange with an estimated equity value of $371 million and a cash balance of $48 million
• Red Light Holland’s CEO Todd Shapiro will lead the new company, while Creso Pharma will appoint four directors to HighBrid's seven-person board

Read the Full Article on The Market Herald here